Stéphanie Lord-Fontaine

Stéphanie Lord-Fontaine has been appointed to Oncopole, a newly created R&D and investment hub for cancer research. Oncopole was established last February as a partnership between the Fonds de Recherche du Québec — Santé (FRSQ) and Merck & Co Inc, the latter of which is contributing $15 million over three years. Lord-Fontaine’s appointment was announced just three days after the release of Quebec’s new life sciences strategy. She has more than 15 years of experience in the academic and biopharmaceutical sectors as well as with research funding agencies. Prior to joining Oncopole, Lord-Lafontaine was senior director, scientific affairs at Genome Quebec which she joined in 2007 as a scientific program manager.  Lord-Lafontaine holds a PhD in biochemistry from the Univ of Quebec at Montreal where she also completed a post-doctoral fellowship in neuroscience.